Kobiety, które przeszły detransycję, zgłaszają niezaspokojone potrzeby: Medyczna tranzycja nie rozwiązała dysforii

Narracje dorosłych zarejestrowanych jako kobiety przy urodzeniu, które rozpoczęły medyczną tranzycję i później przeszły detransycję

Wywiady i badania jakościowe Detransycja i żal Opieka i wsparcie dla osób detrans

Authors: Jane Lomax, Catherine Butler
Journal: Archives of Sexual Behavior
Year: 2025
Source: link.springer.com/article/10.1007/s10508-025-03083-9#ref-CR61

Summary

Researchers interviewed six UK women who medically transitioned and later detransitioned, looking for shared themes. All had taken testosterone for 1 to 5 years, and four had had both breasts removed. Four themes emerged. First, hormones and surgery did not resolve their distress or change their sex. Second, they worried about the long-term health effects of testosterone. Third, their sense of belonging changed, and some felt more at home among women and lesbian communities. Fourth, detransition was an ongoing process, and their needs were mostly not met by health services. The authors call for careful whole-person assessment before transition, research on testosterone's long-term effects in women, and better support for people detransitioning. It gives a detailed picture of a few lives, but six similar, self-selected people cannot show how common this is.

Key findings

Przeprowadzono wywiady z sześcioma brytyjskimi dorosłymi urodzonymi jako kobiety, w wieku 21–32 lat. Wszyscy przyjmowali testosteron przez 1–5 lat, zaczynając w wieku 17–24 lat, cztery miały usunięte obie piersi, a detransycję przeszły od 2 miesięcy do 5 lat wcześniej.
Medyczna tranzycja miała ograniczenia: hormony i operacje nie rozwiązały w pełni ich cierpienia związanego z płcią ani leżących u podstaw problemów ze zdrowiem psychicznym, a niektóre osoby po zmianach fizycznych odczuwały większe cierpienie lub cierpienie z powodu zmienionego ciała.
Obawy o zdrowie w dłuższej perspektywie wpływały na decyzje: obawa przed nieznanymi skutkami testosteronu w ciele kobiety, takimi jak ryzyko dla serca, kurczenie się macicy i niepłodność, przyczyniła się do detransycji, a osoby te czuły, że wcześniej nie zostały właściwie poinformowane.
Poczucie przynależności zmieniało się z czasem: wiele osób odkryło, że bardziej czuje się sobą, łącząc się ze społecznościami kobiet i lesbijek niż żyjąc jako mężczyźni, a niektóre uświadomiły sobie, że wąskie wyobrażenia o tym, czym jest kobieta, ukształtowały ich pierwszą decyzję o tranzycji.
Detransycja była złożona i trwała: przyniosła żałobę, poczucie winy i problemy praktyczne, takie jak życie z bardziej męskim wyglądem, a większość znalazła sposoby radzenia sobie z cierpieniem inne niż leczenie medyczne.
Wsparcia w większości brakowało: opisywały potrzeby niezaspokojone przez lekarzy i terapeutów i często zwracały się do internetowych społeczności osób po detransycji po informacje, praktyczne rady i wsparcie emocjonalne.
Cztery z sześciu osób miały diagnozę autyzmu (lub, w jednej części artykułu, autyzmu albo ADHD).

Abstract

The visibility and presence of people who have detransitioned following a gender transition is growing, with an increase in research on the needs and experiences of this group. This study presents a thematic narrative analysis of interviews from six females (M = 25.5 yrs; range = 21–32 yrs). All detransitioned after having at least one gender-affirming medical or surgical treatment as part of a gender transition in the UK. Four narrative themes were developed to capture how they made sense of their detransition: (1) the limits of medical transition, (2) the longer-term health implications, (3) the social limits of transition, and (4) detransition as an ongoing process. Participants discussed a range of emotional, practical, and other support needs, largely unmet by healthcare or other services. These findings highlight the importance of ensuring that people have realistic expectations of transition as part of a holistic assessment process. Long-term health outcome research is also needed, addressing the impact of testosterone on female anatomy and health specifically. Further clinical implications with those considering transition or detransition are discussed.

Conclusion

This research adds an in-depth analysis to the previous literature on detransition. Participants detransitioned because they found medical transition had limits to resolve distress, or to change their sex. The ongoing health implications and associated risks were also a factor for most. Participant perception of social group belonging often shifted after transition, sometimes linked to feminist values, or perhaps reflecting the normal developmental experiences and trajectory of adolescence and early adulthood as young people explore their identities in different social contexts. It is also possible that the experience of the physical limits of transition to transform them, left the social aspects feeling hollow, increasing social dysphoria related to the new gender. Detransition was a complex and individual, ongoing process, with a range of needs expressed. Implications for clinical practice with people considering transition and detransition were discussed.

Methodological limitations

Very small group: Six people is suitable for in-depth interviews, but cannot show how common these experiences are among detransitioners, let alone among everyone who transitions.
Very similar people: All were White and UK-born, lesbian, bisexual or asexual/lesbian, had at least started university, and were aged 21 to 32. Four had an autism (or, in one part of the paper, autism or ADHD) diagnosis. Results may not carry over to people born male, older people, ethnic minorities or straight detransitioners.
People chose to take part through detransition networks: They were found via Twitter, the r/detrans forum on Reddit, a Facebook 'gender discourse' group and the UK Detransition Advocacy Network. People active in these spaces may hold particular views of transition, and the authors note their group may resemble those in Littman (2021) and Vandenbussche (2022).
One interview, looking back: Each story was told once (in 2021) and may be shaped by how people now make sense of their lives. The authors note experiences may be reinterpreted or left out as people's sense of themselves changes.
Medical history not checked: Diagnoses, treatments, timing and what they were told before treatment all rely on what people said, with no check of medical records.
Dates not recorded: The years of transition and detransition were not collected, so experiences cannot be linked to particular UK clinic rules or periods.
Researchers' influence: One interviewer (the first author) did all the interviews, and the authors admit that being women who do not identify as trans, and the interview relationship, will have shaped the stories told.
Little checking with the interviewees: Summaries and themes sent to the six interviewees for checking got no replies. The person with lived experience who reviewed materials was also found via Reddit and may share their views.
Other paths to detransition left out: Detransitioners born male, people who transitioned again, and people who detransitioned for outside reasons such as stigma or lack of access were not included. The authors also did not look closely at changing gender identity.
No comparison group: Without interviewing people who continued to transition, the study cannot say which experiences (such as health worries or changing sense of belonging) are specific to those who detransition.

detrans.ai

Summary

Key findings

Abstract

Conclusion